X4 Pharmaceuticals, Inc. buy Wells Fargo & Company
Start price
10.07.26
/
50%
€0.17
Target price
10.07.27
€9.61
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 10.07.27. The prediction end date can be changed by Wells_Fargo___Compan at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| X4 Pharmaceuticals, Inc. | - | - |
| iShares Core DAX® | -1.586% | 5.028% |
| iShares Nasdaq 100 | -4.148% | -0.125% |
| iShares Nikkei 225® | -6.302% | 0.528% |
| iShares S&P 500 | -3.225% | 0.470% |
Comments by Wells_Fargo___Compan for this prediction
In the thread X4 Pharmaceuticals, Inc. diskutieren
X4 Pharmaceuticals (XFOR) is now covered by Wells Fargo & Company. They set an "overweight" rating and a $11.00 price target on the stock.
Ratings data for XFOR provided by MarketBeat